Articles: pain-management-methods.
-
Anasthesiol Intensivmed Notfallmed Schmerzther · Sep 2012
Review[Pathophysiology and epidemiology of pain in thoracic surgery].
Acute and chronic pain are significant problems after thoracic surgery with a multifactorial pathogenesis. On the one hand iatrogenic procedures as surgical access and complexity of treatment procedures, and on the other hand constitutional factors as psychosocial comorbidities affect individual pain threshold and the development of a Postthoracic Pain Syndrome (PTPS). ⋯ The characterization of pathophysiological pathways wants to point out treatment options. In conclusion there is a need for well organized, multimodal pain therapy concepts to minimize the risk of perioperative and chronic pain.
-
Anasthesiol Intensivmed Notfallmed Schmerzther · Sep 2012
Review[Systemic and regional analgesia in patients undergoing major thoracic surgery].
Effective, aggressive treatment of pain accompanied with thoracic surgery is important and beneficial for patients, since severe postoperative pulmonary complications and long-term pain will be reduced. In this systematic issue evidence-based strategies in preventing and treating pain after thoracic surgery will be reviewed.
-
Review
Proposed physician payment schedule for 2013: guarded prognosis for interventional pain management.
As happens every year, on July 1, 2012, the Centers for Medicare and Medicaid Services issued a proposed policy and payment rate for services furnished under the Medicare physician fee schedule for 2013. The proposed rule would provide certified registered nurse anesthetists to practice independent interventional pain management. Other issues, though no less important, include a 27% sustainable growth rate formula cut in reimbursement, along with a 2% sequester, which could lead to a potential cut of 29%. ⋯ Since then, Congress has intervened on multiple occasions to prevent additional cuts from being imposed. In this manuscript, we will describe important proposed changes to the physician fee schedule. Additionally, the impact of multiple changes on interventional pain management will be briefly described.
-
Review
Efficacy and safety of neuromodulators in inflammatory arthritis: a Cochrane systematic review.
To determine the efficacy and safety of neuromodulators for pain management in patients with inflammatory arthritis. ⋯ Based on 3 small trials, which were all at high risk of bias, there is weak evidence that nefopam and capsaicin are superior to placebo in reducing pain in patients with RA, but both are associated with a significant side effect profile. There are no available data for other types of IA or for newer agents such as gabapentin or pregabalin.
-
To determine the efficacy and safety of opioid analgesics in inflammatory arthritis (IA). ⋯ Based on 11 heterogeneous studies of short duration and high risk of bias, there is weak evidence that opioids are effective analgesics in RA. AE are common and may offset the benefits. The relative risks and benefits of opioids in IA beyond 6 weeks are unknown.